Viking Therapeutics
VKTX
#3512
Rank
A$5.34 B
Marketcap
A$46.28
Share price
-4.69%
Change (1 day)
-0.60%
Change (1 year)

Market capitalization of Viking Therapeutics (VKTX)

Market cap: A$5.34 Billion

As of March 2026 Viking Therapeutics has a market cap of A$5.34 Billion. This makes Viking Therapeutics the world's 3512th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Viking Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026A$5.34 B-14.76%
2025A$6.27 B-14.91%
2024A$7.37 B169.88%
2023A$2.73 B157.93%
2022A$1.05 B113.4%
2021A$0.49 B-7.4%
2020A$0.53 B-35.37%
2019A$0.82 B6.47%
2018A$0.77 B330.76%
2017A$0.18 B443.13%
2016A$33.29 M-26.54%
2015A$45.32 M

End of Day market cap according to different sources

On Mar 22nd, 2026 the market cap of Viking Therapeutics was reported to be:

A$5.34 Billion
by Nasdaq info icon info icon
A$5.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
A$2.74 B-48.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$9.18 B 71.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
A$0.17 B-96.70%๐Ÿ‡บ๐Ÿ‡ธ USA